Medical robotics is the use of robotic systems to assist with surgery, rehabilitation, medication delivery, and diagnostics in healthcare settings. These machines range from multi-armed surgical platforms controlled by a surgeon at a console to wearable exoskeletons that help stroke patients relearn how to walk, to pharmacy robots that package and deliver medications within a hospital. The field has expanded rapidly over the past two decades, and robotic systems now play a role in nearly every major medical specialty.
How Surgical Robots Work
The most widely recognized form of medical robotics is the surgical robot. These systems don’t operate independently. A surgeon sits at a nearby console, looking through a high-definition 3D display, and controls robotic arms that hold miniature surgical instruments. The robot translates the surgeon’s hand movements into smaller, more precise motions inside the patient’s body. Each robotic arm typically has seven degrees of freedom, meaning it can bend and rotate in ways a human wrist cannot, which is especially useful in tight, hard-to-reach spaces.
The leading platform is the da Vinci Surgical System, made by Intuitive Surgical. It uses three or four robotic arms and is considered the gold standard in robotic surgery, with applications across urology, gynecology, cardiac surgery, colorectal procedures, and general surgery. Newer competitors are gaining ground. The Versius system from CMR Surgical uses a modular design where individual arms can be repositioned and reconfigured for different procedures, making it more adaptable and less expensive. Medtronic’s Hugo RAS system offers a built-in training simulator and also comes at a lower cost than the da Vinci. All three provide 3D visualization, though only the da Vinci currently offers haptic feedback, the feature that lets the surgeon “feel” tissue resistance through the controls.
That sense of touch matters more than you might expect. Haptic feedback systems use sensors embedded in the instrument tips, including tiny capacitive sensors and force-sensitive resistors, to measure how much pressure the tools are exerting on tissue. That data is relayed back to the console through small motors or pneumatic systems that push against the surgeon’s fingertips, recreating the sensation of pulling, pressing, or cutting. Some systems skip physical feedback entirely and instead display force data as a color-coded overlay on the surgeon’s screen.
What Surgical Robots Are Used For
Robotic-assisted surgery is now common for prostate removal, hysterectomy, hernia repair, gallbladder removal, and colorectal procedures. It has also moved into emergency surgery settings, where robotic systems are increasingly used for gallbladder removal, colon resection, and both inguinal and ventral hernia repairs. More complex operations like pancreas surgery also benefit from the enhanced precision of robotic arms.
The clinical advantages show up most clearly when comparing robotic surgery to traditional open surgery. In one study of 60 patients undergoing prostate removal, those who had the robotic procedure lost an average of 103 milliliters of blood compared to 418 milliliters with open surgery, and went home after about one day instead of two. A larger matched comparison of 120 patients found even starker differences: hospital stays of three days versus six, and blood loss of 200 milliliters versus 800. Similar patterns appear in gynecologic surgery. A comparison of 58 patients undergoing removal of uterine fibroids found blood loss nearly cut in half (196 ml vs. 365 ml) and hospital stays reduced from 3.6 days to 1.5. A meta-analysis of 21 controlled studies across gynecology confirmed that robotic procedures consistently result in shorter hospital stays and less blood loss than open surgery.
Rehabilitation Robots and Exoskeletons
Beyond the operating room, medical robots are helping patients recover movement after strokes, spinal cord injuries, and neurological conditions. Robotic exoskeletons are wearable frames that attach to a patient’s legs (and sometimes torso) and use motorized joints to guide movement during walking practice. The idea is to give the brain repeated, consistent input about what proper walking feels like, reinforcing neural pathways that were damaged.
A study of 19 stroke patients using the EksoNR exoskeleton three times per week for four weeks showed meaningful gains. Their performance on a standard mobility test improved by about 10 seconds on average, dropping from roughly 49 seconds to 38 seconds. More strikingly, the number of steps patients could take during a session more than doubled, rising from about 407 to 913. Walking time per session nearly doubled as well, going from around 17 minutes to 30 minutes. Improvements were seen across nearly every measure of body movement and daily function, with walking ability showing the largest gains.
The FDA classifies powered lower extremity exoskeletons as Class 2 medical devices, meaning they require safety testing and regulatory clearance before clinical use. International safety standards specifically address robots that physically interact with patients during rehabilitation, covering requirements for both basic safety and essential performance.
Robots in Pharmacies and Hospital Logistics
Some of the most common medical robots never touch a patient. Hospital pharmacies increasingly rely on dispensing robots that store individually packaged tablets and capsules on internal rods, pick the correct doses for each patient, and place them in labeled envelopes for distribution. This reduces the risk of human error in medication preparation, which is one of the most frequent sources of preventable harm in hospitals.
Automation has expanded into sterile drug preparation as well. Robotic systems now handle the mixing of intravenous chemotherapy drugs and total parenteral nutrition (liquid nutrition delivered through an IV) inside clean rooms, tasks that require exact dosing and contamination-free environments. Pneumatic tube systems, which use compressed air to shoot cylindrical containers through a network of tubes, rapidly transport medications, lab samples, and supplies between the central pharmacy and hospital floors. Newer systems go further, using self-navigating mobile robots equipped with mapping technology to autonomously deliver medications to patients and manage inventory.
The Cost Question
Robotic systems are expensive, and that cost is the biggest barrier to wider adoption. A detailed economic analysis found that robotic prostate surgery cost an average of about $19,360 per patient in Canadian dollars, compared to $14,735 for the standard laparoscopic approach, a difference of roughly $4,600 per case. In U.S. dollars, one study found median direct costs of $6,752 for robotic prostatectomy versus $5,687 for laparoscopic and $4,437 for open surgery.
The pattern holds across specialties. For hysterectomy, robotic procedures consistently cost more than laparoscopic ones. One study found adjusted total hospital costs of $9,640 for robotic inpatients versus $6,973 for laparoscopic. Another put the figures at $50,758 for robotic versus $41,436 for laparoscopic. The gap narrows somewhat when you factor in shorter hospital stays and fewer complications, but the upfront equipment cost, ongoing maintenance, and specialized training required for surgical teams keep per-procedure costs higher. This is why robotic surgery is more common at large medical centers that can spread the investment across a high volume of cases.
Artificial Intelligence and Increasing Autonomy
Current surgical robots are fully controlled by a human surgeon. That is starting to change. The Smart Tissue Autonomous Robot, known as STAR, has performed bowel reconnection procedures on both lab models and live tissue, matching and in some cases outperforming human surgeons. When tested on phantom bowels, STAR made fewer mistakes than surgeons, and fluid flowed more smoothly through the bowel it reconstructed.
AI is also entering diagnostics. A deep learning system trained on over 128,000 retinal photographs achieved 97.5% sensitivity and 93.4% specificity in detecting diabetic eye disease, performing at a level comparable to ophthalmologists. In another application, a machine learning system predicted lung cancer staging from insurance claims data alone with 93% accuracy, outperforming a traditional guidelines-based approach that achieved just 72%. Even blood draws are being automated: an experimental robot called Veebot identifies the best vein to target about 83% of the time, roughly matching human performance.
These systems aren’t replacing clinicians. They’re handling specific, well-defined tasks where precision and consistency matter most, while human judgment still guides the overall plan of care.